Medical cannabis edibles production set to launch in Missouri
One of the newest medical cannabis markets to launch – Missouri – has yet to see dispensaries stock their shelves with edibles, […]
Category: Cannabis Industry & Marijuana Business Briefs
Biden to pick attorney general soon; choice could favor marijuana industry
President-elect Joe Biden told reporters Monday he plans to identify his attorney general this week, a cabinet post that could be critical […]
How US House lawmakers voted on the marijuana legalization bill
The U.S. House of Representatives on Friday passed the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act by a margin of 228-164. Here’s […]
5 cannabis industry predictions for 2021 from MJBizDaily CEO Chris Walsh
The coming year will bring the cannabis industry new state legalization initiatives and a resurgence of investment but is unlikely to result […]
Ayr borrows $75 million to fund marijuana acquisitions, finish facilities
Multistate marijuana operator Ayr Strategies announced a $75 million secured loan intended to fund acquisitions and complete facilities in Arizona, Ohio and […]
MJBizCon advice: Assess cannabis strategy and prepare for next crisis
The coronavirus pandemic forced the marijuana industry to “grow up” and now provides a unique opportunity for companies to reevaluate their business […]
MJBizCon speaker eyes consumer data to market to cannabis, CBD users
The uncertain regulatory environment in the hemp extract and CBD category is leading to an “explosion” of competitive crowding and consumer confusion, […]
Brazil official sees cannabis cultivation bill making progress in December
A Brazilian bill that would legalize medical marijuana and industrial hemp cultivation could soon have its first debate on the floor of […]
Los Angeles selects 200 social equity cannabis retail license finalists
Los Angeles regulators issued the much-anticipated list of 200 finalists in the contentious battle for social equity marijuana retail permits. But it’s […]
DEA asks court to toss marijuana rescheduling appeal
The U.S. Drug Enforcement Administration reiterated that a lawsuit challenging marijuana’s classification as a Schedule 1 drug under the federal Controlled Substances […]